The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126191452 12619145 2 F 20160713 20160809 20160803 20160822 EXP BR-ELI_LILLY_AND_COMPANY-BR201607009384 ELI LILLY AND CO 0.00 F Y 0.00000 20160819 CN BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126191452 12619145 1 PS INSULIN, LISPRO INSULIN LISPRO 1 Transplacental 8 IU, QD BEFORE BREAKFEST U U 20563 8 IU INJECTION QD
126191452 12619145 2 SS INSULIN, LISPRO INSULIN LISPRO 1 Transplacental 4 IU, QD BEFORE LUNCH U U 20563 4 IU INJECTION QD
126191452 12619145 3 SS INSULIN, LISPRO INSULIN LISPRO 1 Transplacental 4 IU, QD BEFORE DINNER U U 20563 4 IU INJECTION QD
126191452 12619145 4 SS HUMULIN N INSULIN HUMAN 1 Transplacental 22 IU, EACH MORNING U U 0 22 IU INJECTION QD
126191452 12619145 5 SS HUMULIN N INSULIN HUMAN 1 Transplacental 22 IU, EACH EVENING U U 0 22 IU INJECTION QD
126191452 12619145 6 SS HUMULIN R INSULIN HUMAN 1 Transplacental UNK, UNKNOWN U U 0
126191452 12619145 7 C LANTUS INSULIN GLARGINE 1 Unknown 8 IU, QD U 0 8 IU QD
126191452 12619145 8 C PURAN LEVOTHYROXINE SODIUM 1 Unknown 125 UG, UNKNOWN U 0 125 UG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126191452 12619145 1 Gestational diabetes
126191452 12619145 4 Gestational diabetes
126191452 12619145 6 Gestational diabetes
126191452 12619145 7 Gestational diabetes
126191452 12619145 8 Hypothyroidism

Outcome of event

Event ID CASEID OUTC COD
126191452 12619145 OT
126191452 12619145 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126191452 12619145 Cardiac disorder
126191452 12619145 Exposure during breast feeding
126191452 12619145 Foetal exposure during pregnancy
126191452 12619145 Hypoglycaemia
126191452 12619145 Hypothermia
126191452 12619145 Lung disorder

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126191452 12619145 1 20160429 0
126191452 12619145 2 20160429 0
126191452 12619145 3 20160429 0
126191452 12619145 4 20160422 0
126191452 12619145 5 20160422 20160506 0